Aura Biosciences, Inc. AURA Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s foreign currency translation gains (losses)?
- Aura Biosciences, Inc. (AURA) reported foreign currency translation gains (losses) of -$27K in Q1 2026.
- How has Aura Biosciences, Inc.'s foreign currency translation gains (losses) changed year-over-year?
- Aura Biosciences, Inc.'s foreign currency translation gains (losses) decreased by 28.6% year-over-year, from -$21K to -$27K.
- What does foreign currency translation gains (losses) mean?
- The gains or losses resulting from the translation of financial statements from foreign functional currencies into the reporting currency. This metric reflects the impact of exchange rate fluctuations on the company's international assets and liabilities. It is essential for understanding how global operations or foreign-denominated holdings affect the company's overall financial position.